FMIblog

  The global   Pharmacovigilance Market   is on a robust growth trajectory, projected to surge from an estimated USD 9,025.2 million in 2025 to USD 20,977.1 million by 2035, exhibiting a compelling Compound Annual Growth Rate (CAGR) of 8.8% over the forecast period. This significant expansion is primarily fueled by the escalating incidence of adverse drug reactions (ADRs), the increasing global prevalence of chronic diseases, and the continuous growth of the pharmaceutical industry. Driving Forces: Demand for Drug Safety and Technological Integration The intensified demand for effective drug safety monitoring systems has spurred substantial investments in advanced pharmacovigilance solutions. Stringent regulatory requirements worldwide, coupled with the critical need for real-time data analysis, are accelerating the adoption of sophisticated pharmacovigilance practices. A pivotal driver of this market expansion is the seamless integration of artificial intelligence (AI) a...

The global hyperbaric oxygen therapy (HBOT) devices market is poised for significant expansion, with projections indicating a rise from USD 3.83 billion in 2025 to USD 6.35 billion by 2035, demonstrating a robust Compound Annual Growth Rate (CAGR) of 5.2%. This impressive growth is largely fueled by the escalating global burden of chronic wounds, a surge in post-surgical complications, and increasing incidences of decompression illnesses. A growing understanding among both clinicians and patients regarding the multifaceted therapeutic benefits of HBOT is driving its adoption in hospitals, specialty clinics, and outpatient centers as a crucial component of integrated treatment protocols. Mono-place Chambers Lead the Charge in Accessibility and Efficiency A key driver of this market surge is the increasing preference for mono-place hyperbaric chambers, which are projected to hold a commanding 61.1% market share in 2025. These single-patient units offer compelling advantages, includi...

 The global Automated Breast Ultrasound Systems (ABUS) market is set for a substantial surge, projected to grow from an estimated USD 2,312.5 million in 2025 to USD 5,424.6 million by 2035 . This impressive expansion reflects a robust Compound Annual Growth Rate (CAGR) of 8.9% over the forecast period. The market's significant momentum is driven by the escalating global prevalence of breast cancer and the inherent limitations of conventional mammography, particularly in women with dense breast tissue. ABUS technology offers a critical solution by providing standardized, reproducible imaging outcomes with reduced operator dependency, thereby enhancing diagnostic confidence and improving early detection rates. The increasing adoption of supplemental imaging modalities, coupled with supportive regulatory approvals and favorable reimbursement policies in developed markets, is firmly integrating ABUS into routine screening protocols. Competitive Landscape and Technological Advanceme...

The global stroke catheters market is on a rapid ascent, projected to reach an impressive USD 2,054.4 million by 2035 , a substantial increase from its USD 960.5 million valuation in 2025 . This significant expansion, marked by a robust Compound Annual Growth Rate (CAGR) of 7.9% over the forecast period, is primarily fueled by the escalating demand for minimally invasive procedures and the continuous integration of advanced technologies that enhance the efficacy of stroke interventions. The industry's growth is further bolstered by the rising global incidence of stroke-related conditions, the critical need for improved diagnostic solutions, and a growing emphasis on reducing healthcare costs through more efficient treatments. The market's transformative trajectory is underscored by recent innovations. As Wayne Allen, CEO of Perfuze, noted on March 12, 2025, during the PULSE 2.0 event, "The Zipline catheters represent an innovative technology that I believe will simplif...

The global bioinformatics market is poised for an unprecedented surge, projected to nearly triple from USD 18.7 billion in 2025 to an estimated USD 58.1 billion by 2035 . This remarkable growth trajectory, reflecting a robust Compound Annual Growth Rate (CAGR) of 12% over the forecast period, is driven by transformative advancements in next-generation sequencing, the pervasive integration of AI-powered analytics, and the exponential generation of data across genomics and proteomics. This robust expansion is underpinned by an escalating global demand for precision medicine, groundbreaking innovations in drug discovery, and the imperative for integrated healthcare data solutions. Governments and private entities worldwide are significantly increasing capital investments into 'omics' infrastructure, fostering dynamic collaborative ecosystems between leading research institutions, pharmaceutical companies, and computational laboratories. For instance, public-private initiatives...

The global gene editing tool market is on track to advance at a CAGR of 18.4% from 2024 to 2034 . In 2024, the valuation is standing around USD 688.1 million and is projected to expand to USD 3,713.1 million by 2034 . The industry is set to gain traction during the forecast period owing to the increased prevalence of genetic diseases globally. As we step into a new decade, the field of biotechnology is undergoing rapid transformation—driven largely by the extraordinary potential of gene editing tools. From CRISPR-Cas9 to TALENs and beyond, these technologies have revolutionized how scientists understand, manipulate, and treat genetic material. Between 2025 and 2035, the gene editing tools market is expected to witness unprecedented growth, reshaping not just healthcare, but agriculture, industrial biotechnology, and beyond. Get Sample Report: - https://www.futuremarketinsights.com/reports/sample/rep-gb-9544 What Are Gene Editing Tools? Gene editing tools are biotechnologica...